-transparent.png){kind=logo}
Twenty-three patients with chromomycosis were treated with oral 5-fluorocytosine for periods ranging from 2 to 67 months. Sixteen were considered cured, after 3 consecutive monthly controls showing healing of the lesions and absence of fungi in mycologic and histopathologic examinations of biopsy specimens. Seven, in spite of initial clinical improvement, showed resistance to treatment. Associated treatment with amphotericin B, calciferol or thiabendazole failed to help patients resistant to 5-fluorocytosine. Resistance seems to occur especially in those with long-standing lesions or widespread involvement.
Related Publications
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
February 1979,
Journal of cutaneous pathology,
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
February 1983,
Journal of the American Academy of Dermatology,
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
December 1974,
The British journal of dermatology,
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
December 1985,
The Ceylon medical journal,
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
February 1977,
The Journal of dermatology,
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
June 1987,
International journal of dermatology,
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
January 1983,
Medicina cutanea ibero-latino-americana,
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
January 1970,
Revista de investigacion en salud publica,
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
February 1974,
American journal of clinical pathology,
C F Lopes, and
R J Alvarenga, and
E O Cisalpino, and
M A Resende, and
L G Oliveira
March 1975,
International journal of dermatology,
